Cargando…
Anticancer activity of 2’-hydroxyflavanone towards lung cancer
In previous studies, we found that 2'-hydroxyflavonone (2HF), a citrus flavonoid, inhibits the growth of renal cell carcinoma in a VHL-dependent manner. This was associated with the inhibition of glutathione S-transferases (GSTs), the first step enzyme of the mercapturic acid pathway that catal...
Autores principales: | Awasthi, Sanjay, Singhal, Sharad S., Singhal, Jyotsana, Nagaprashantha, Lokesh, Li, Hongzhi, Yuan, Yate-Ching, Liu, Zheng, Berz, David, Igid, Henry, Green, William C., Tijani, Lukman, Tonk, Vijay, Rajan, Aditya, Awasthi, Yogesh, Singh, Sharda P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281421/ https://www.ncbi.nlm.nih.gov/pubmed/30546837 http://dx.doi.org/10.18632/oncotarget.26329 |
Ejemplares similares
-
2'-Hydroxyflavanone: A novel strategy for targeting breast cancer
por: Singhal, Jyotsana, et al.
Publicado: (2017) -
Topical 2′-Hydroxyflavanone for Cutaneous Melanoma
por: Bose, Chhanda, et al.
Publicado: (2019) -
2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer
por: Nagaprashantha, Lokesh Dalasanur, et al.
Publicado: (2018) -
Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer
por: Nagaprashantha, Lokesh Dalasanur, et al.
Publicado: (2022) -
RLIP76, a Glutathione-Conjugate Transporter, Plays a Major Role in the Pathogenesis of Metabolic Syndrome
por: Singhal, Jyotsana, et al.
Publicado: (2011)